Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer. [electronic resource]
Producer: 20040528Description: 3526-33 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Area Under Curve
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Time Factors
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.